Company Profile for NeurOp, Inc.

--()--NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Alzheimer’s and Parkinson’s diseases. Its research targets various subunits of neuronal NMDA receptors and their potential therapeutic benefit. The company has licensed its technology to Bristol-Myers Squibb for the development of a compound for treatment-resistant depression. Multi-year funding from the NIH supports NeurOp's research and development programs for schizophrenia, Alzheimer’s disease and NP10679, its drug candidate for the prevention of ischemic damage during a stroke or subarachnoid hemorrhage. For more information, please visit www.neuropinc.com or follow us on LinkedIn.

 

Company:

        NeurOp, Inc.
 

Headquarters Address:

58 Edgewood Ave., NE
Atlanta, GA 30303
 

Main Telephone:

9192605595
 

Website:

www.neuropinc.com

 

Type of Organization:

Private
 

Industry:

Biotechnology
 

Key Executives:

CEO: Barney Koszalka

 

Public Relations

Contact:

Robin Fastenau

Phone:

9193499824